BACKGROUND Approximately 25% of all cases of atypical ductal hyperplasia (ADH)
diagnosed on core biopsy of the breast are associated with ductal carcinoma in situ (DCIS) …

Atypical ductal hyperplasia (ADH), flat epithelial atypia (FEA), and lobular neoplasia (LN)
form a group of early precursor lesions that are part of the low-grade pathway in breast …

A growing body of evidence support the association between the use of hormone
replacement therapy (HRT) and a higher risk of both invasive lobular carcinoma (ILC) and …

One in twelve American women will develop breast cancer, with infiltrating lobular
carcinoma (ILC) comprising approximately 15% of these cases. The incidence of ILC has …

Purpose. The purpose was to evaluate the mammographic and sonographic (US) features of
lobular carcinoma in situ (LCIS). Methods. Mammographic and US findings of nine lesions …

Lobular carcinoma in situ (LCIS) is not only a relative newcomer among breast lesions, but
in its short span of 50 years in has gradually evolved from a rare form of breast cancer to …

The limitations of mammography in the detection and evaluation of invasive lobular
carcinoma (ILC) have long been recognized, presenting real clinical challenges in treatment …

Background Atypical lesions and lobular carcinoma in situ (LCIS) are associated with an
increased risk of breast malignancy. The utility of breast magnetic resonance imaging (MRI) …

Pleomorphic lobular carcinoma in situ (PLCIS) of the breast is a rare variant of lobular
carcinoma in situ (LCIS). We reviewed 78 cases of PLCIS diagnosed at our institution from …

Purpose Lobular carcinoma in situ (LCIS) is a marker of increased risk of breast cancer.
Current guidelines do not recommend mastectomy as a strategy for risk reduction for most …